Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 41Pancreatic Neoplasms 17Breast Neoplasms 17Esophageal Neoplasms 14Neoplasms 13Stomach Neoplasms 12Lung Neoplasms 12Triple Negative Breast Neoplasms 11Rectal Neoplasms 11Neoplasm Metastasis 11Esophageal Squamous Cell Carcinoma 11Uterine Cervical Neoplasms 10Colorectal Neoplasms 10Small Cell Lung Carcinoma 9Ovarian Neoplasms 9Head and Neck Neoplasms 7Nasopharyngeal Carcinoma 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Leukemia, Myeloid, Acute 5Endometrial Neoplasms 5Colonic Neoplasms 5Recurrence 4NSCLC 4Mouth Neoplasms 4Lymphoma 3Glioma 3Cholangiocarcinoma 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2

Interventions

Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Locally Advanced Resectable Rectal Cancer × Drug Therapy × Clear all
NCT07454720 2026-05-05

A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 2/3 Recruiting
165 enrolled
Gastrointestinal

Locally Advanced Resectable Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡